TY  - GEN
AU  - Fischel,Jean-Louis
AU  - Ciccolini,Joseph
AU  - Formento,Patricia
AU  - Ferrero,Jean-Marc
AU  - Milano,Gérard
TI  - Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridine
SN  - 0959-4973
PY  - 2006///1212
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Antineoplastic Agents, Hormonal
KW  - Antineoplastic Agents, Phytogenic
KW  - Cell Line, Tumor
KW  - Cell Size
KW  - Cell Survival
KW  - drug effects
KW  - Docetaxel
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Erlotinib Hydrochloride
KW  - Floxuridine
KW  - Humans
KW  - Male
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Quinazolines
KW  - Taxoids
KW  - Thymidine Phosphorylase
KW  - metabolism
KW  - Thymidylate Synthase
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1097/01.cad.0000224444.23953.90
ER  -